Results 251 to 260 of about 47,538 (286)
Some of the next articles are maybe not open access.

CARDIOTOXICITY OF AMITRIPTYLINE

The Lancet, 1972
Abstract A hospital-based drug-information system has been used to extend preliminary work on the incidence of sudden unexpected death in patients with a diagnosis of cardiac disease who had been prescribed amitriptyline. The finding that there were 13 sudden unexpected deaths in a group of 119 amitriptyline patients compared with only 3 in a ...
D C, Moir   +6 more
  +9 more sources

Amitriptyline for depression

Cochrane Database of Systematic Reviews, 2007
For many years amitriptyline has been considered one of the reference compounds for the pharmacological treatment of depression. However, new tricyclic drugs, heterocyclic compounds and selective serotonin reuptake inhibitors have been introduced on the market with the claim of a more favourable tolerability/efficacy profile.The aim of the present ...
G, Guaiana, C, Barbui, M, Hotopf
openaire   +2 more sources

Chronopharmacology of amitriptyline

Clinical Pharmacology and Therapeutics, 1983
Side effects of decreased salivation and sedation were more marked when a single dose of amitriptyline was taken orally in the morning than in the evening. These dynamic differences were due to alteration in kinetics. Absorption of the drug was more rapid in the morning, although other kinetic parameters, especially total bioavailability, were ...
S, Nakano, L E, Hollister
openaire   +2 more sources

Amitriptyline and Amitriptyline-with-Perphenazine in Depression—A Retrospective Study

British Journal of Psychiatry, 1967
The object of this paper is to assess, in retrospect, the relative effectiveness of amitriptyline (‘Triptizol’) and amitriptyline with perphenazine (‘Triptafen’) in the treatment of depressed patients.
C, Chacón, E T, Downham
openaire   +2 more sources

AMITRIPTYLINE POISONING

The Lancet, 1963
D M, DAVIES, R, ALLAYE
openaire   +2 more sources

Amitriptyline Cardiotoxicity

Chest, 1974
W K, Hong   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy